Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development

Rhea-AI Summary

Green Hygienics Holdings Inc. (OTCQB: GRYN) has appointed David Racz as Senior Vice President of Global Sales and Business Development. Racz brings extensive experience from top pharmaceutical companies like Pfizer, GlaxoSmithKline, and Novartis. His background includes leading significant sales expansions and managing large teams internationally. Racz's expertise in the cannabis industry since 2008 includes acquiring cannabinoid patents and advancing cannabis genetic engineering. Green Hygienics focuses on high-quality hemp cultivation and processing, aiming to deliver premium bioactive cannabinoids.

Positive

• David Racz's extensive experience in the pharmaceutical and cannabis industries may enhance Green Hygienics' growth prospects.
• Racz's leadership could strengthen the company's global sales and business development capabilities.

Negative

• Potential concerns regarding continuity and integration of Racz's new leadership in the company.

SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces the appointment of David Racz as Senior Vice President of Global Sales and Business Development.  

Mr. David Racz has held global, senior level positions with distinguished pharmaceutical companies including Pfizer, GlaxoSmithKline, and Novartis. He began his pharmaceutical career at Pfizer Pharmaceuticals where he became vice president of sales and human resources and managed the largest expansion in Pfizer’s sales force in history.  

Shortly thereafter, SmithKline Beecham recruited David to manage over 4,000 employees in 20 countries throughout Asia, Latin America, Australia, and South Africa in sales, marketing, and research and development. He was also a key member of the team responsible for orchestrating the unparalleled transcontinental merger of SmithKline and Beecham.  

In 2002, David was recruited by Novartis Pharmaceuticals as senior vice president North America. In this capacity, he delivered strategy and resource allocation for an $8 billion health care company and oversaw 14,000 global employees in pharmaceutical operations, global oncology, manufacturing and R&D.  

Further, David was Senior Vice President for Mona Vie Inc. (“Mona Vie”), the fastest-growing private company in the food and beverage industry. With annual sales in excess of $942 million, David facilitated growth exceeding 100% per quarter, year over year, while in this role.

Over the past 10 years David has amassed a wealth of knowledge and experience in the cannabis industry. He began his cannabis career in 2008, in Colorado where he worked with legislative bodies to develop the then emerging medical cannabis laws.

In 2011 working under multiple controlled substance license(s) issued from The Canadian Department of Health, David led a team that was responsible for:

• Acquisition and/or application of 6 cannabinoid related patents
• Discovery of 2 previously unidentified cannabis chemical structures
• Amassed a cannabis DNA library of over 4000 strains
• Early advancement of cannabis genetic engineering for application in large scale production.

He has served as a U.S. Army medical service corps officer, achieving the rank of major, and was awarded numerous times for service and merit. David earned his bachelor’s degree from Wayne State University and his master’s degree from Troy University. 

About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

Hygienics is the science of preserving and promoting the health of individuals, communities, and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at:  http://www.greenhygienics.com/

Follow us on  Facebook, Twitter, Instagram and Linkedin

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299 

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

FAQ

What is the significance of David Racz's appointment at Green Hygienics (GRYN)?

David Racz's appointment as Senior Vice President of Global Sales and Business Development is significant due to his extensive background in top pharmaceutical companies, which may drive growth for Green Hygienics.

How does David Racz's experience benefit Green Hygienics (GRYN)?

Racz's experience from leading pharmaceutical firms and his involvement in the cannabis industry could provide valuable insights and strategies for expanding Green Hygienics' market presence.

What is Green Hygienics' focus in the market following the appointment of David Racz (GRYN)?

Following Racz's appointment, Green Hygienics continues its focus on high-standard cultivation of industrial hemp and the manufacturing of pharmaceutical-grade bioactive cannabinoids.

What are the expected outcomes of David Racz joining Green Hygienics (GRYN)?

The expected outcomes include enhanced sales strategies and potential growth in market share due to Racz's experience in sales and business development.